CHEK2 Antibody

ProSci
Product Code: PSI-13-179
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-13-179-50uL50uL£433.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Shipping:
Blue Ice or RT
Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Images

1 / 5
Western blot analysis of extracts of various cell lines, using CHEK2 antibody (13-179) at 1:1000 dilution.<br/>Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.<br/>Lysates/proteins: 25ug per lane.<br/>Blocking buffer: 3% nonfat dry milk in TBST.
2 / 5
Immunohistochemistry of paraffin-embedded human lung cancer using CHEK2 antibody (13-179) at dilution of 1:100 (40x lens).
3 / 5
Immunofluorescence analysis of HeLa cells using CHEK2 antibody (13-179). Blue: DAPI for nuclear staining.
4 / 5
Immunofluorescence analysis of A549 cells using CHEK2 antibody (13-179).
5 / 5
Immunoprecipitation analysis of 200ug extracts of MCF-7 cells using 1ug CHEK2 antibody (13-179). Western blot was performed from the immunoprecipitate using CHEK2 antibody (13-179) at a dilition of 1:1000.

Western blot analysis of extracts of various cell lines, using CHEK2 antibody (13-179) at 1:1000 dilution.<br/>Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.<br/>Lysates/proteins: 25ug per lane.<br/>Blocking buffer: 3% nonfat dry milk in TBST.
Immunohistochemistry of paraffin-embedded human lung cancer using CHEK2 antibody (13-179) at dilution of 1:100 (40x lens).
Immunofluorescence analysis of HeLa cells using CHEK2 antibody (13-179). Blue: DAPI for nuclear staining.
Immunofluorescence analysis of A549 cells using CHEK2 antibody (13-179).
Immunoprecipitation analysis of 200ug extracts of MCF-7 cells using 1ug CHEK2 antibody (13-179). Western blot was performed from the immunoprecipitate using CHEK2 antibody (13-179) at a dilition of 1:1000.

Further Information

Additional Names:
Chk2 Antibody: CDS1, CHK2, LFS2, RAD53, hCds1, HuCds1, PP1425, CDS1, CHK2 checkpoint homolog, Hucds1
Application Note:
WB: 1:500 - 1:2000

IHC: 1:50 - 1:100

IF: 1:50 - 1:200

IP: 1:20 - 1:50
Background:
In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene.
Buffer:
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Concentration:
batch dependent
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 1-220 of human CHEK2 (NP_009125.1).
NCBI Gene ID #:
11200
NCBI Official Name:
CHK2 checkpoint homolog (S. pombe)
NCBI Official Symbol:
CHEK2
NCBI Organism:
Homo sapiens
Physical State:
Liquid
PREDICTED MOLECULAR WEIGHT:
Observed: 60kDa
Purification:
Affinity purification
Research Area:
Apoptosis, Cancer, Cell Cycle, Signal Transduction
Swissprot #:
O96017
User NOte:
Optimal dilutions for each application to be determined by the researcher.